Veteran investor Dr Robert Glassman talks life sciences, immunotherapy and Umoja
Seattle-based pre-clinical biotech Umoja Biopharma aims to revolutionise immunotherapy by retooling the patient’s immune system in vivo. Based on the…
Latest Oncology
-
6 days
-
1 week
-
2 weeks
-
2 weeks
-
6 days
-
1 week
-
2 weeks
-
2 weeks
AstraZeneca withdraws antibody Imfinzi indication for bladder cancer in US
AstraZeneca has announced the voluntary withdrawal of the human monoclonal antibody Imfinzi (durvalumab) indication in the US for previously treated…
Latest News
View More
Lilly and Merus partner to develop T-Cell re-directing antibody therapies
Research and development group of Eli Lilly and Company, Loxo Oncology at Lilly, and clinical-stage oncology company Merus have announced a research collaboration and exclusive…
FDA approves Pfizer’s Xalkori in ALCL in children, young adults
The US Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for Pfizer’s Xalkori (crizotinib) for treating paediatric patients aged one…
Boehringer enters into cancer drug development deal with Enara Bio
Boehringer Ingelheim has entered into a strategic collaboration and licensing agreement with Enara Bio to research and develop new targeted…
Servier to acquire oncology business from Agios Pharmaceuticals for $2bn
Pharmaceutical company Servier has signed an agreement to acquire Agios Pharmaceuticals’ oncology business including its commercial, clinical and research-stage oncology…
Boehringer to acquire NBE-Therapeutics for $1.43bn
Boehringer Ingelheim has signed a binding agreement to acquire all shares of clinical-stage Swiss biotechnology company NBE-Therapeutics for a total…
Arcus Biosciences and WuXi Biologics expand deal for antibodies development
Biopharmaceutical company Arcus Biosciences has expanded its existing strategic relationship with Chinese company WuXi Biologics to discover anti-CD39 antibodies using…
Company A-Z
View More
Latest Content
View More
Quercis enlists Clinipace for Phase III trial in pancreatic cancer-related venous thromboembolism; in $40m-$60m fundraise, CEO says
Quercis Pharma is working with the CRO Clinipace in a Phase III trial of Kinisoquin (isoquercetin) for venous thromboembolism (VTE)…
LoA Update: BeiGene’s Phase III tislelizumab for esophageal squamous cell carcinoma sees 10-point jump for FDA approval forecast
As of 29 January, the US likelihood of approval (LoA) for BeiGene’s Phase III anti-PD-1 antibody for esophageal squamous cell carcinoma (ESCC)…
R-Pharm to Use Frewitt Milling Technology
R-Pharm, a Russian medical company, has announced they will be using fine micronisation technology from Swiss mill manufacturer Frewitt. The…
Unlocking the Power of a Connected Workforce
The way organizations have been connecting workers to the digital space is expensive, slow, and difficult for users. It also…
Covid-19 Vaccine Distribution Monitoring Made Easy
The global Covid-19 vaccines distribution task is a complicated operation and implementing an easy solution to monitor this process is…
Cell Harvest Using Only One Filter Per Batch
As the biologics industry is moving towards more diverse batch volumes and cell concentrations that are cultivated in single-use facilities,…